Cognizant services will provide automation and
digital technologies that can reduce cost of service and speed time
to market
TEANECK,
N.J., March 25, 2024 /PRNewswire/
-- Cognizant (NASDAQ: CTSH) announced today it has been
selected by Clario, a healthcare research technology company that
delivers leading endpoint technology solutions for clinical trials,
to support its global IT infrastructure and applications. The
collaboration will help Clario advance its employee and customer
offerings in support of its mission to transform lives by
generating high-quality evidence for more informed decision
making.
"At Clario, we pride ourselves on providing the best technology
for our customers and we do that by creating a robust and
innovative ecosystem," said Jay
Ferro, EVP, Chief Information, Technology & Product
Officer at Clario. "Cognizant's innovative technology and industry
expertise made them the natural choice to partner on the next phase
of our digital transformation journey."
Clario develops digital solutions that redefine possibilities in
clinical trials by enhancing the accuracy, reliability, speed, and
efficiency of data gathering and analysis. Over the course of the
five-year relationship, Clario will leverage Cognizant's experience
in automation and digital technologies for process and experience
modernization, supporting:
- Achieving faster time to market by streamlining workflows and
enhancing collaboration across teams.
- Building a foundation for a digital enterprise by integrating
data, analytics, and AI capabilities across the company.
- Driving cutting edge innovation in the clinical trials space by
adopting agile methodologies and best practices.
"Clinical trials require secure and reliable technology to
manage patient data, monitor results, ensure regulations are met,
and more." said Cognizant's Mohammad
Haque, SVP, Global Large Deals Lead and BU Head, Life
Sciences. "Clario is doing groundbreaking work in providing this
technology to run clinical trials, and Cognizant is excited to work
alongside them to modernize their offerings."
About Cognizant
Cognizant (Nasdaq: CTSH) engineers
modern businesses. We help our clients modernize technology,
reimagine processes and transform experiences so they can stay
ahead in our fast-changing world. Together, we're improving
everyday life. See how at www.cognizant.com or @cognizant.
About Clario
Clario is a leading healthcare research
and technology company that generates the highest quality clinical
evidence for pharmaceutical, biotech, and medical device partners.
They offer comprehensive evidence generation solutions that combine
eCOA, cardiac safety, medical imaging, precision motion, and
respiratory endpoints.
Clario's global team of science, technology, and operational
experts have helped deliver over 26,000 trials and contributed to
over 800 regulatory approvals in more than 100 countries. For more
than 50 years, they have delivered deep scientific expertise and
the most comprehensive endpoint technologies to help transform
lives around the world.
U.S.
|
Europe /
APAC
|
India
|
Name Natalie
Steffen
|
Name Christina
Schneider
|
Name Rashmi
Vasisht
|
Email
natalie.steffen@cognizant.com
|
Email
christina.schneider@cognizant.com
|
Email
rashmi.vasisht@cognizant.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/clario-selects-cognizant-as-global-strategic-technology-services-provider-to-optimize-and-advance-their-clinical-transformation-journey-302097723.html
SOURCE Cognizant Technology Solutions Corporation